Nigrostriatal Dopamine Acting on Globus Pallidus Regulates Sleep

Cerebral Cortex

Volumn 26, Issue 4, 2016, Pages 1430-1439

  Qiu, Mei Hong ^a,b   Yao, Qiao Ling ^b   Vetrivelan, Ramalingam ^b   Chen, Michael C ^b   Lu, Jun ^b  

^a FUDAN UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

dopamine; globus pallidus; Parkinson's disease; sleep; substantia nigra pars compacta

Indexed keywords

OXIDOPAMINE; DOPAMINE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CAUDOPUTAMEN; CONTROLLED STUDY; ELECTROENCEPHALOGRAPH; GLOBUS PALLIDUS; GLOBUS PALLIDUS EXTERNA; MALE; NERVE CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; OPTOGENETICS; PRIORITY JOURNAL; RAT; SLEEP WAKING CYCLE; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL STRIATUM; WAKEFULNESS; ANIMAL; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; NERVE TRACT; PHYSIOLOGY; SLEEP; SPRAGUE DAWLEY RAT;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; GLOBUS PALLIDUS; MALE; NEURAL PATHWAYS; PARS COMPACTA; RATS; RATS, SPRAGUE-DAWLEY; SLEEP; WAKEFULNESS;

EID: 84963823228     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhu241     Document Type: Article

References (45)

1. Bass CE, Grinevich VP, Kulikova AD, Bonin KD, Budygin EA. 2013. Terminal effects of optogenetic stimulation on dopamine dynamics in rat striatum. J Neurosci Methods. 214:149-155.
2. Belaid H, Adrien J, Laffrat E, Tande D, Karachi C, Grabli D, Arnulf I, Clark SD, Drouot X, Hirsch EC, et al. 2014. Sleep disorders in parkinsonian macaques: effects of l-Dopa treatment and pedunculopontine nucleus lesion. J Neurosci. 34:9124-9133.
3. Burgess CR, Tse G, Gillis L, Peever JH. 2010. Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy. Sleep. 33:1295-1304.
4. Cooper AJ, Stanford IM. 2001. Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro. Neuropharmacology. 41:62-71.
5. Dahan L, Astier B, Vautrelle N, Urbain N, Kocsis B, Chouvet G. 2007. Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep. Neuropsychopharmacology. 32:1232-1241.
6. Dimpfel W. 2008. Pharmacological modulation of dopaminergic brain activity and its reflection in spectral frequencies of the rat electropharmacogram. Neuropsychobiology. 58:178-186.
7. Fifel K, Vezoli J, Dzahini K, Claustrat B, Leviel V, Kennedy H, Procyk E, Dkhissi-Benyahya O, Gronfier C, Cooper HM. 2014. Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates. PLoS One. 9:e86240.
8. Filion M, Tremblay L. 1991. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547:142-151.
9. Fuller PM, Sherman D, Pedersen NP, Saper CB, Lu J. 2011. Reassessment of the structural basis of the ascending arousal system. J Comp Neurol. 519:933-956.
10. Gerashchenko D, Blanco-Centurion CA, Miller JD, Shiromani PJ. 2006. Insomnia following hypocretin2-saporin lesions of the substantia nigra. Neuroscience. 137:29-36.
11. Grace AA, Bunney BS. 1984. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci. 4:2877-2890.
12. GuzmanMS, De Jaeger X, DrangovaM, Prado MA, Gros R, Prado VF. 2013. Mice with selective elimination of striatal acetylcholine release are lean, showaltered energy homeostasis and changed sleep/wake cycle. J Neurochem. 124:658-669.
13. Hasue RH, Shammah-Lagnado SJ. 2002.Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: A combined retrograde tracing and immunohistochemical study in the rat. J Comp Neurol. 454:15-33.
14. Hirayama M, Nakamura T, Hori N, Koike Y, Sobue G. 2008. The video images of sleep attacks in Parkinson's disease. Mov Disord. 23:288-290.
15. Hrabovszky E, Molnar CS, Borsay BA, Gergely P, Herczeg L, Liposits Z. 2013. Orexinergic input to dopaminergic neurons of the human ventral tegmental area. PLoS One. 8:e83029.
16. Hur EE, Zaborszky L. 2005. Vglut2 afferents to the medial prefrontal and primary somatosensory cortices: A combined retrograde tracing in situ hybridization study [corrected]. J Comp Neurol. 483:351-373.
17. Hutchison WD, Lozano AM, Davis KD, Saint-Cyr JA, Lang AE, Dostrovsky JO. 1994. Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients. Neuroreport. 5:1533-1537.
18. Lai YY, Shalita T, Hajnik T, Wu JP, Kuo JS, Chia LG, Siegel JM. 1999. Neurotoxic N-methyl-D-aspartate lesion of the ventral midbrain and mesopontine junction alters sleep-wake organization. Neuroscience. 90:469-483.
19. Laloux C, Derambure P, Houdayer E, Jacquesson JM, Bordet R, Destee A, Monaca C. 2008. Effect of dopaminergic substances on sleep/wakefulness in saline-and MPTP-treated mice. J Sleep Res. 17:101-110.
20. Laloux C, Derambure P, Kreisler A, Houdayer E, Brueziere S, Bordet R, Destee A, Monaca C. 2008. MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations. Exp Brain Res. 186:635-642.
21. Lazarus M, Huang ZL, Lu J, Urade Y, Chen JF. 2012. How do the basal ganglia regulate sleep-wake behavior? Trends Neurosci. 35:723-732.
22. Lazarus M, Shen HY, Cherasse Y, Qu WM, Huang ZL, Bass CE, Winsky-Sommerer R, Semba K, Fredholm BB, Boison D, et al. 2011. Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci. 31:10067-10075.
23. Lipford MC, Silber MH. 2012. Long-term use of pramipexole in the management of restless legs syndrome. Sleep Med. 13: 1280-1285.
24. Lu J, Greco MA, Shiromani P, Saper CB. 2000. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci. 20:3830-3842.
25. Lu J, Jhou TC, Saper CB. 2006. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci. 26:193-202.
26. Lu J, Zhang YH, Chou TC, Gaus SE, Elmquist JK, Shiromani P, Saper CB. 2001. Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J Neurosci. 21:4864-4874.
27. Maillet A, Krainik A, Debu B, Tropres I, Lagrange C, Thobois S, Pollak P, Pinto S. 2012. Levodopa effects on hand and speech movements in patients with Parkinson's disease: A fMRI study. PLoS One. 7:e46541.
28. Miller JD, Farber J, Gatz P, Roffwarg H, German DC. 1983. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Res. 273:133-141.
29. Morton AJ. 2013. Circadian and sleep disorder in Huntington's disease. Exp Neurol. 243:34-44.
30. Mukai K, Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. 2009. Electrophysiological effects of orexin/hypocretin on nucleus accumbens shell neurons in rats: an in vitro study. Peptides. 30:1487-1496.
31. Muschamp JW, Hollander JA, Thompson JL, Voren G, Hassinger LC, Onvani S, Kamenecka TM, Borgland SL, Kenny PJ, CarlezonWA Jr. 2014. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proc Natl Acad Sci USA. 111: E1648-E1655.
32. Paterson JL, Reynolds AC, Ferguson SA, Dawson D. 2013. Sleep and obsessive-compulsive disorder (OCD). Sleep Med Rev. 17:465-474.
33. Paus S, Brecht HM, Koster J, Seeger G, Klockgether T, Wullner U. 2003. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord. 18:659-667.
34. Paxinos G, Watson C. 2009. The rat brain in stereotaxic coordinates. Burlington (MA): Elsevier, Inc.
35. Pritzel M, Markowitsch HJ. 1980. Kainic acid lesions in the cat's thalamus: morphological and behavioral changes. Brain Res Bull. 5:61-67.
36. Qiu MH, LiuW, Qu WM, Urade Y, Lu J, Huang ZL. 2012. The role of nucleus accumbens core/shell in sleep-wake regulation and their involvement in modafinil-induced arousal. PLoS One. 7:e45471.
37. Qiu MH, Vetrivelan R, Fuller PM, Lu J. 2010. Basal ganglia control of sleep-wake behavior and cortical activation. Eur J Neurosci. 31:499-507.
38. Qu WM, Xu XH, Yan MM,Wang YQ, Urade Y, Huang ZL. 2010. Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. J Neurosci. 30:4382-4389.
39. Querejeta E, Delgado A, Valdiosera R, Erlij D, Aceves J. 2001. Intrapallidal D2 dopamine receptors control globus pallidus neuron activity in the rat. Neurosci Lett. 300:79-82.
40. Saper CB. 1984. Organization of cerebral cortical afferent systems in the rat. II. Magnocellular basal nucleus. J Comp Neurol. 222: 313-342.
41. Vetrivelan R, Qiu MH, Chang C, Lu J. 2010. Role of Basal Ganglia in sleep-wake regulation: neural circuitry and clinical significance. Front Neuroanat. 4:145.
42. Videnovic A, Noble C, Reid KJ, Peng J, Turek FW, Marconi A, Rademaker AW, Simuni T, Zadikoff C, Zee PC. 2014. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol. 71:463-469.
43. Wang S, Zhang QJ, Liu J, Wu ZH, Ali U, Wang Y, Chen L, Gui ZH. 2009. The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease. Neuroscience. 162:1091-1100.
44. Zarepour L, Fatahi Z, Sarihi A, Haghparast A. 2014. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine. Neuropeptides. 48:179-185.
45. Zhang QJ, Wang S, Liu J, Ali U, Gui ZH, Wu ZH, Hui YP, Wang Y, Chen L. 2010. Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat. Brain Res. 1312:127-137.